Skip to main content

Economics

Tocilizumab and Drug Shortage Headaches

Sep 22, 2021

Do you know what’s in short supply? Trust, pediatric rheumatologists, and drugs. Since the onset of the pandemic, numerous drug shortages have affected rheumatology, including sulfasalazine, hydroxychloroquine, and now, tocilizumab.

Read Article

ACR Responds to 2022 Medicare Physician Fee Schedule Proposed Rule

ACR
Sep 16, 2021

In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) shared its perspective on the CY 2022 Medicare Physician Fee Schedule and Quality Payment Program proposed rule. 

 



Rheumatology leaders are encouraged by

Read Article
In 2018-2019 Australia spent $136 billion on healthcare with more spent on MSK disorders ($14 billion) than CV Dz ($11.8 billion), cancer ($11.8 billion) & mental Dz ($10.5 billion). CAD, back pain, dementia, COPD & lung cancer caused most $$ burden. https://t.co/WHIPeNGIhf

Dr. John Cush @RheumNow( View Tweet )

Sep 01, 2021

EULAR Points on Managing Difficult Rheumatoid Arthritis

Aug 19, 2021

A EULAR task force has promulgated several points to consider in managing difficult-to-treat RA. These "points" are unique in directing the rheumatologist's attention to the potential for misdiagnosis and the impact of comorbid conditions on what is perceived as poorly controlled RA.

Read Article

ACR Update on Tocilizumab Shortages

ACR
Aug 17, 2021

The American College of Rheumatology (ACR) is actively engaged with the FDA Center for Drug Evaluation and Research (CDER) drug shortage team as they work with the manufacturer to resolve current shortages of tocilizumab (Actemra). Demand for tocilizumab has outpaced supply, with demand

Read Article

USA Ranks 11th (Last) in Healthcare Delivery

Aug 12, 2021

Despite spending more (18%) of its gross national product on health care than its peers, the U.S. ranked 11th (last) according to a comparative study done by The Commonwealth Fund in high-income countries, according to a new study by health policy think tank The Commonwealth Fund.



The

Read Article

Lumbar Spine Decompression Alone is Superior to Decompression with Fusion

Aug 05, 2021

The NEJM has published a multicenter study wherein patients with surgical lumbar spinal stenosis and degenerative spondylolisthesis were found to fair equally well (noninferior if treated with decompression surgery alone compared to decompression with instrumented fusion.

Read Article

CDC Reverses Stance on Masks

Jul 27, 2021

Today the Centers for Disease Control and Prevention (CDC) said that masks should be used by those vaccinated against the coronavirus in public indoor spaces in parts of the country where the virus is surging.



They also recommended universal masking for teachers, staff, students and

Read Article

US News & World Report Ranks Best Rheumatology Hospitals

Jul 27, 2021

Medscape has published the annual U.S. News and World Reports ranking of Rheumatology Hospitals, again honoring Johns Hopkins Hospital with the top spot, with runner up status going to the Cleveland Clinic, Hospital for Special Surgery, Mayo Clinic and Brigham and Women's Hospital.

Read Article

Osteonecrosis in Lupus

Jul 15, 2021

A single center analysis of systemic lupus erythematosus (SLE) patients found symptomatic osteonecrosis (ON) in nearly 10%.



Researchers analyzed data from 912 SLE patients admitted to the hospital (1981 to 2012).  Of these 912 SLE patients, 97 had symptomatic ON with an overall

Read Article

Arthritis as a Harbinger of Pediatric Cancer

Jul 15, 2021

Lancet Rheumatology has published a cohort analysis showing that a small but significant subset of children presenting with arthralgia or arthritis may have a pediatric malignancy.



This multicentre study sought to identify articular presentations of children manifesting

Read Article

ICYMI: 2020 Rheumatology Year in Review

Jul 08, 2021

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items

Read Article

ICYMI: Rheumatologists Rank 2nd in Physician Burnout

Jul 06, 2021

The 2021 Medscape Survey on Physician burnout ranks rheumatology second, just behind Critical Care medicine.

The survey included over 12,000 physcians from 20 specialties. While 42% of MDs claimed to be burnt-out, Rheumatologists claimed this 50% of the time. The top 3 this year were Critical

Read Article

ICYMI: Actemra FDA Approved for Systemic Sclerosis Interstitial Lung Disease

Jul 06, 2021

Genentech announced Thursday that the US Food and Drug Administration approved tocilizumab (Actemra) for the treatment of Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), specifically indicated for slowing the rate of decline in pulmonary function in adults SSc-ILD.

Read Article

ICYMI: JAK Inhibitor Misses Endpoint in Safety Study. Now What?

MedPage Today
Jul 05, 2021

Pfizer announced results Wednesday from its FDA-mandated postmarketing safety study of tofacitinib (Xeljanz), and they don't bode well for the drug and possibly others in its class.



Compared with patients taking tumor necrosis factor (TNF) inhibitors, those assigned to tofacitinib (5

Read Article

Gender Trends in Rheumatology

Jul 01, 2021

A study of rheumatologists in Ontario, Canada has shown an increasing percentage of women in rheumatology; unfortunately they have lower salaries but see fewer patients than do their older, male colleagues.



Between 2000 to 2015 the number of full time rheumatologists increased from 89

Read Article

New ACR Rheumatoid Arthritis Guideline: Emphasis on Methotrexate

MedPage Today
Jun 29, 2021

The American College of Rheumatology (ACR) has issued new guidelines on the treatment of rheumatoid arthritis, addressing questions about initial treatment with methotrexate and minimizing reliance on glucocorticoids. Use of these medications in specific high-risk populations also was

Read Article

The Potential of Rituximab Efficacy in Systemic Sclerosis

Jun 28, 2021

Rituximab (RTX) has been in the news a lot lately; more surprisingly for its potential benefits in progressive systemic sclerosis (SSc).

Ebata and colleagues have published the results of a double-blind, randomised, placebo-controlled trial comparing intravenous RTX to placebo in 56 SSc

Read Article

ACR Stands Against Insurer Mandated Infusion Locations

ACR
Jun 28, 2021

The American College of Rheumatology (ACR) has released an updated position statement on patient safety and site of service for biologics outlining several reasons why the ACR strongly believes infusions should be administered in a monitored health care setting with onsite supervision by a

Read Article

RheumNow Podcast – Modern Treatment of RA Pregnancy (6.25.2021)

Jun 25, 2021

Dr. Jack Cush reviews this week’s news and journal reports featured on RheumNow.com.

Read Article

Efficacy of 6 Weeks Antibiotics with Prosthetic Joint Infections

May 27, 2021

The NEJM has published the results of a French multicenter study showing that prosthetic joint infections can be successfully managed with 6 weeks of antibiotic therapy; this was noninferior and had better outcomes compared to 12 weeks of antibiotic therapy.



Prosthetic joint

Read Article

Congress Slams AbbVie Over Price Hikes, 'Frivolous' Patents

MedPage Today
May 24, 2021

House lawmakers on both sides of the aisle pummeled AbbVie CEO Richard Gonzalez for raising the price of two widely used drugs and for the company's "legally questionable" tactics to head off competition from biosimilars, despite pulling in healthy profits.



Much of Tuesday's House

Read Article

RheumNow Podcast – BandAids for Rheumatologists (5.14.2021)

May 14, 2021

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com - a website for rheumatologists, by rheumatologists.



We love Rheumatology!




  1. CDC study from 33 sites, 25 states showed vaccine efficacy (against Sx COVID) in HCP was 82% with ONEdose

Read Article

Insurers Bet Big on Bribing Patients

Madelaine Feldman, MD, and Jay Salliotte
May 11, 2021

Last month, psoriasis patients covered by Cigna received a curious letter from the insurance giant's pharmacy management division. They could receive a $500 debit card from Cigna, with just one string attached: they would have to switch to a different medication, one preferred by the insurer

Read Article

Higher Hydroxychloroquine Blood Levels Reduces Thrombosis Risk in Lupus

May 10, 2021

Petri and colleagues have published that measuring hydroxychloroquine (HCQ) blood levels can be useful in systemic lupus erythematosus (SLE), as low levels are associated with an increased thrombotic risk in SLE.



In total cohort of 739 SLE patients, HCQ levels were serially quantified

Read Article
×